biosafety level 2

Deep research

Generated by just research-trait; source: research/traits/ecology/biosafety_level_2-deep-research-falcon.md

# Curation report: biosafety level 2 (METPO:1001103)

## Executive conclusion

**Biosafety level 2 (BSL-2) should not be represented as an intrinsic microbial phenotype.** It is a context-dependent containment assignment produced by an integrated risk assessment of the agent or strain, the procedure and scale, exposure routes, worker susceptibility, and available preventive or therapeutic measures. The most defensible TraitMech model is therefore an **agent–activity–host–control causal graph**, with `METPO:1001103` as the risk-management outcome rather than as a direct consequence of one gene or pathway.

BSL-2 covers work with moderate-hazard agents associated with human disease and occupational exposure through ingestion, inoculation, mucous-membrane/skin contact, or inhalation. Relative to BSL-1, it adds restricted access, agent-specific training, PPE and primary containment—especially a biological safety cabinet (BSC) for aerosol- or splash-generating work. BSL-3 is the nearby higher boundary for work whose inhalation route and potential for serious or lethal disease demand enhanced containment. Risk group and containment level are related but not interchangeable; no taxonomic label or virulence determinant alone is sufficient to assign BSL-2. (ta2018biosafetyandbiohazards pages 3-6, kimman2008evidencebasedbiosafetya pages 18-19, kimman2008evidencebasedbiosafetya pages 7-8)

## 1. Scope and boundary cases

### What the trait represents

For curation, define the trait as:

> **A laboratory containment/risk-management class appropriate to an agent–procedure combination presenting moderate individual and environmental hazard, commonly involving agents associated with human disease in the community, where standard microbiological practices plus restricted access, PPE, decontamination and primary containment can control anticipated exposures.**

This preserves the supplied METPO definition while making explicit that the observable property is an **assigned containment level**, not a physiological capacity or environmental preference.

### Boundaries

- **Versus BSL-1:** BSL-2 adds restricted access, specific training and physical containment for aerosol/splash procedures. BSL-1 organisms are generally not known consistently to cause disease in immunocompetent adults. (ta2018biosafetyandbiohazards pages 3-6)
- **Versus BSL-3:** BSL-3 addresses agents or procedures with greater inhalational risk and serious or potentially lethal disease, normally requiring all viable-agent manipulations in a BSC and additional engineering controls. (robilotti2023biosafetyandbiohazard pages 3-4)
- **Versus Risk Group 2:** risk group describes inherent agent hazard; BSL describes the controls selected for a particular activity. Strain attenuation, concentration, volume, aerosol generation, animal work or genetic modification can shift the containment required.
- **Clinical specimens:** unknown patient specimens are frequently processed under BSL-2 practices even though the eventual agent may require referral or escalation. Thus, “handled in a BSL-2 clinical laboratory” is not evidence that the recovered organism is intrinsically a BSL-2 organism. Clinical laboratories also face equipment- and workflow-specific aerosol hazards not captured by research-laboratory guidance. (cornish2021clinicallaboratorybiosafety pages 16-18)
- **Attenuated or engineered derivatives:** an attenuated derivative may warrant lower controls than its wild type, while restoration of replication competence, expanded host range, toxin expression or an antibiotic-resistance marker can increase risk. A 2016 BSL-2 incident involving an inadvertently infectious recombinant HIV-1 pseudovirus illustrates why construct-level assessment is essential. (zuo2024ahistoricalstudy pages 8-10)
- **Quantity and procedure:** containment can differ between small-dose clinical administration and bulk preparation. T-VEC, for example, may be administered as a single-dose injection using BSL-1 practices and universal precautions, while blanket BSL-2 rules are often imposed by treatment centers. (robilotti2023biosafetyandbiohazard pages 3-4)

## 2. Candidate nodes grouped by type

### Trait and assessment nodes

- **biosafety level 2** — `METPO:1001103`
- moderate laboratory biological hazard — label-only candidate
- laboratory biosafety risk assessment — label-only candidate
- probability of exposure — label-only candidate
- consequence of exposure — label-only candidate
- laboratory-acquired infection — label-only candidate
- community-associated human disease — label-only candidate

### Agent and host properties

- virulence / disease severity — label-only candidate
- infectivity and infectious dose — label-only candidate
- transmission route
- host range
- host susceptibility / immunocompromised state
- environmental persistence
- replication competence
- viable pathogen burden or concentration
- culture volume / scale
- availability of effective vaccine
- antimicrobial or antiviral susceptibility
- antimicrobial resistance

Classification frameworks evaluate virulence, mode of transmission and host range, preventive measures and treatment together; variation among strains can alter containment needs. (kimman2008evidencebasedbiosafetya pages 7-8)

### Experimental and environmental factors

- aerosol-generating manipulation
- centrifugation

Showing the first 60 of 273 lines of findings; the linked file also carries the run's front matter and the prompt it was given — read the full report.